| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 1 |
| 1 | CARBOPLATIN | 1 |
| 2 | CISPLATIN | 1 |
| 3 | FLUOROURACIL | 1 |
| 4 | FLUOROURACIL CREAM, 0.5% | 1 |
| 5 | LEVONORGESTREL | 1 |
| 6 | METHYLERGONOVINE | 1 |
| 7 | MITOMYCIN | 1 |
| 8 | MYCOPHENOLATE MOFETIL | 1 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOMYCIN | 1 | 0.0003 |
| 1 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 2 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 3 | FLUOROURACIL | 1 | 0.0000 |
| 4 | CISPLATIN | 1 | 0.0000 |
| 5 | BEVACIZUMAB | 1 | 0.0000 |
| 6 | CARBOPLATIN | 1 | 0.0000 |
| 7 | MYCOPHENOLATE MOFETIL | 1 | 0.0000 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0.0000 |
| 9 | LEVONORGESTREL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Progestin [EPC] | 1 | 0.0000 |
| 5 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |